AU6492400A - Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene - Google Patents

Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene

Info

Publication number
AU6492400A
AU6492400A AU64924/00A AU6492400A AU6492400A AU 6492400 A AU6492400 A AU 6492400A AU 64924/00 A AU64924/00 A AU 64924/00A AU 6492400 A AU6492400 A AU 6492400A AU 6492400 A AU6492400 A AU 6492400A
Authority
AU
Australia
Prior art keywords
2gene
polymorphisms
prostaglandin
drug target
endoperoxide synthase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU64924/00A
Inventor
R. Rex Denton
Krishnan Nandabalan
Angela Sanchis
Joel Claiborne Stephens
Debra A. Tanguay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU6492400A publication Critical patent/AU6492400A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU64924/00A 1999-07-22 2000-07-24 Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene Withdrawn AU6492400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14517099P 1999-07-22 1999-07-22
US60145170 1999-07-22
PCT/US2000/020114 WO2001007662A1 (en) 1999-07-22 2000-07-24 Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2 gene

Publications (1)

Publication Number Publication Date
AU6492400A true AU6492400A (en) 2001-02-13

Family

ID=22511910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64924/00A Withdrawn AU6492400A (en) 1999-07-22 2000-07-24 Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene

Country Status (2)

Country Link
AU (1) AU6492400A (en)
WO (1) WO2001007662A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004033692A1 (en) * 2002-10-08 2004-04-22 Bayer Healthcare Ag Human prostaglandin g/h synthase 2 splice variant
US10837014B2 (en) 2012-05-16 2020-11-17 Translate Bio Ma, Inc. Compositions and methods for modulating SMN gene family expression
KR20150030205A (en) 2012-05-16 2015-03-19 라나 테라퓨틱스, 인크. Compositions and methods for modulating smn gene family expression
US20150152410A1 (en) 2012-05-16 2015-06-04 Rana Therapeutics, Inc. Compositions and methods for modulating mecp2 expression
WO2013173645A1 (en) * 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating utrn expression
CA2873769A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics Inc. Compositions and methods for modulating hemoglobin gene family expression
CN104583401A (en) 2012-05-16 2015-04-29 Rana医疗有限公司 Compositions and methods for modulating ATP2A2 expression
NO344051B1 (en) * 2017-05-04 2019-08-26 Patogen As Novel virus in Fish and Method for detection

Also Published As

Publication number Publication date
WO2001007662A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
AU2743801A (en) Sensors with improved properties
AU3678100A (en) Biosensor
ZA200201124B (en) Humidity controller.
AU4420800A (en) Position sensor
EP1116800A4 (en) Sputtering target
AU7683700A (en) Co sensor
AUPQ417699A0 (en) Ball return arrangement
AU2311500A (en) Position sensing
AU6492400A (en) Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene
AU1289001A (en) Sensor assembly
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU5848600A (en) Glass-mounted sensor
GB9907861D0 (en) The tracker
AU4808200A (en) Dna balls
AU2000236029A1 (en) Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU4098000A (en) The swinging doggy ball
AU7024700A (en) Position sensor
AU2000277254A1 (en) Drug target isogenes: polymorphisms in the interleukin-4 gene
AU2000233075A1 (en) Dartboard
AU7933700A (en) Sensors
GB9920137D0 (en) The blockage buster
GB9916598D0 (en) The target game
AU2001234807A1 (en) Drug target isogenes: polymorphisms in the angiotensin receptor 2 gene

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant